AmerisourceBergen Corporation: Bearish AB=CD & 3 Drives PatternABC currently is Bearishly Diverging on the MACD and RSI around the 2.414-2.618 PCZ of a Bearish AB=CD where it has also developed a Bearish 3 Drives Pattern and a Bearish Shark. If we get the action I'm expecting to see from here, it will come down and break through the trend line and then continue down to the 0.886 retrace at $77 in a dramatic way.
Healthcare
Hot News Trade!Based on Phase 2 data evaluation we could expect a positive outcome. Information sound good so far. THese kind of news often cause a wild rally on the day. Maybe two days. But generally they dont last long. Depends on the news of course.
But I would expect a pop on this on monday or tuesday. Maybe interesting for a short trade.
Cigna Group, RSI Bullish Divegrence at the 800 Day EMACigna is showing quite a bit of RSI Bullish Dievegrence as it trades at the 800-Day EMA for the second time; we could eventually see this result in a rally to atleast make a 50%-78.6% retrace.
Life Health showing downside to R16.23 but with a warning!Inverse Reverse C and H has formed on Life Health.
The price did close below the brim level which also happened to be on the 200MA.
This is a big test for the company.
Once the price breaks below 200MA, there is a high chance of it closing the gap and dropping further.
21>7
Price -200 - Test
RSI<50 - lower highs
Target R16.23
It is a medium probability trade to take on.
ABOUT THE COMPANY
Establishment:
Life Healthcare Group Holdings Ltd, often simply known as Life Healthcare, is a South Africa-based company that was founded in 1983.
Healthcare Provider:
Life Healthcare is a leading private hospital operator in South Africa. It offers acute hospital care, acute mental healthcare, renal dialysis, and acute rehabilitation, among other services.
International Presence:
Life Healthcare has an international footprint and operates in various countries including India through Max Healthcare, and the United Kingdom through Alliance Medical.
Expansion into Diagnostic Imaging:
Life Healthcare expanded its healthcare offering in 2016 with the acquisition of Alliance Medical, which is a leading independent provider of medical imaging services within Europe.
$IWM Outlook 05/30 - 06/02 @capgainsgroupAs the S&P 500 and the NASDAQ rally into the green for the year, the Russell 2000 (aka the small cap index) has lagged behind and is barely green at +1.03% YTD for 2023. One of the reasons why this index hasn’t been doing well can be attributed to the index’s 15.18% allocation in the Finance Sector. Failing regional banks such as Silicon Valley Bank ( NASDAQ:SIVB ) and Signature Bank ( OTC:SBNY ) haven’t helped the index much.
Investors who would like to play the Russell 2000 should pay attention to the 5 major sectors that makes up 73.23% of AMEX:IWM : Health Care (17.62%), Industrials (16.66%), Financials (15.18%), Information Technology (12.74%), and Consumer Discretionary (11.03%).
Technical Analysis:
AMEX:IWM recently formed a Death Cross (50 SMA x 200 SMA) on the daily chart in mid April. Although not very clean, there is a support uptrend line dating back to October 2022. Also, it seems like we have a head and shoulders pattern, using the Daily 170.30 level as the neckline.
Bulls will want price to reclaim the weekly 178.90 level as a support.
I lean bearish on this index. If AMEX:IWM can’t reclaim the two daily gaps above, at 176.74 - 177.42 and 180.53 - 181.28, I expect it to come down and test the yellow uptrend line and potentially break it to the downside in the coming weeks.
Upside Targets: 176.74 → 177.42 → 180.71 → 181.28 → 183.76 Extended: 186.91
Downside Targets: 174.09 → 172.33 → 171.41 → 170.30 → 169.32 Extended: 166.81
MODERNA $305 | Bidding at $220 and $150 Informed Players and speculators at Sub $100 levels are booking gains
we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle
Vaccine COViD was intense HiV was the sell on News..
we await next Drama and Biden Policy on Healthcare etc..
for now Watch or Chrun at key leves (eyeball the box)
3M Position Trade✨ NEW: 3M...UT (3M, 3D) ✨ POSITION TRADE ✨
BLO1 @ 74.34
BLO2 @ 50.99 (Wealth Trade - I may never let this position go)
TP1 @ 112.53 (shave 25% from BLO 1)
TP2 @ 175.83 (shave 25% from BLO 1)
TP3@ 215.82 (shave 25% from BLO 1)
3M Co. is a technology company that creates industrial, safety, and consumer products. They operate under different segments such as Safety and Industrial, Transportation and Electronics, Health Care, and Consumer.
Recently, the company has faced a major challenge involving around 260,000 pending lawsuits due to their military earplugs malfunctioning. The outcome of these legal proceedings could greatly impact 3M, either causing severe consequences or presenting a unique investment opportunity.
Our team predicts that despite the uncertainty, institutions will likely intervene and purchase 3M's stock as it returns to its established pattern of gradual and steady growth, also known as the company's intrinsic or true value. However, it is important to acknowledge that the future outcome is still subject to change and could sway in either direction.
Here is my strategy: I plan to sell 25% of my BLO1 holdings at every take profit point, while keeping the remaining amount for a long-term investment. However, I have no plans to sell any of my BLO2 holdings and will be holding them for the long term. This is commonly referred to as the "diamond hand strategy."
Happy Trading‼️
$ISRG buy or sell?Intuitive Surgical is in the Medical-Systems/Equip Group, develops an advanced surgical system designed to improve open surgery and minimally invasive surgery.
After the earnings gap up, price has been still going up but volume has been drecreasing along with momentum.
This bearish divergnece is signaling a needed pause for $NASDAQ:ISRG.
Even if breaks above $309 before correcting I wouldn't buy it as I don't expect it would have a good follow through.
I'll keep this stock in the watchlist and wait for a proper breakout.
TRHC WCA - Cup and Handle Pattern Company: Tabula Rasa HealthCare, Inc.
Ticker: TRHC
Exchange: NASDAQ
Sector: Healthcare
Introduction:
Hello, traders and investors! Today we are analyzing Tabula Rasa HealthCare Inc (TRHC) on the weekly scale chart. We'll specifically be observing a classic price pattern known as a cup and handle, which may serve as a bottom reversal.
Cup and Handle Pattern:
The cup and handle is a reversal pattern that can act as bullish continuation aswell. It signifies a period of consolidation followed by a breakout. It resembles the shape of a tea cup and can indicate a strong buy signal when correctly identified.
Analysis:
Tabula Rasa's price chart was previously characterized by a clear downtrend, represented by a blue diagonal resistance line. Now, it seems to be forming a cup and handle pattern with a clear horizontal resistance at $6.51.
However, the 200 EMA is currently pointing towards a bearish environment, which raises some doubts about a bullish setup. Despite this, a breakout above the horizontal resistance could open up the possibility of a long position, albeit with a smaller position size due to the current bearish indication.
In the event of a valid breakout, our estimated price target stands at $10.80. This corresponds to a potential increase of approximately 66.24%. Thus, Tabula Rasa HealthCare qualifies as a watchlist candidate, albeit one that requires caution.
Conclusion:
The weekly chart for Tabula Rasa HealthCare Inc reveals a potential cup and handle pattern, which may serve as a bottom reversal. However, the current bearish environment suggested by the 200 EMA calls for caution. A valid breakout above the pattern's resistance could offer a long position opportunity.
As always, please conduct your own due diligence and consider risk management strategies before making any trading decisions.
Thank you for joining this analysis. If you found it useful, please like, share, and follow for more market insights. Happy trading!
Best regards,
Karim Subhieh
$INSP near completing head & shoulder patternInspire Medical Systems develops innovative and minimally invasive solutions for patients with obstructive sleep apnea.
Ranks #10 in the IBD Group Medical-Products Group with a Relative Strength IBD Rating of 93. This is a what leader looks like.
Today is forming a daily shark patter with a pivot buy at $278.10.
The follow through would be a breakout above $283, which would confirm the head & shhoulders pattern.
I like these odds, I will buy those breakouts if volume is behind the moves.
The RSI hasn't touch the oversold zone and has showed 3 bullish divergence within this long base.
Let's waitn for the breakout!
Bursa Healthcare Index Possible REBOUNDCandlestick Healthcare Index rebound from support.
reversal coming if can break resistance.
TARGET REACHED: Life Health struck our target 1 at R21.34 W Formation formed, we then had some high volatility around the price.
Luckily, the stop loss would have been below the pattern.
The indicators were all showing bullish signs.
7>21>200
RSI>50
Target struck at R21.34
ABOUT THE COMPANY
Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
Life Healthcare is one of the largest private healthcare providers in South Africa, operating 66 hospitals and healthcare facilities across the country.
The company employs over 19,000 people and serves over 4 million patients per year.
Life Healthcare provides a wide range of medical services, including acute hospital care, mental health services, renal dialysis, and oncology care.
Life Healthcare has a partnership with the South African National Blood Service to support blood donation drives and increase awareness about the importance of blood donation.
$MPW, healthcare REIT stock bombed out but not depletedI think it's time to take another look at MPW and see it's potential both based on it's classification as a REIT but also based on the sector it mostly plays in, Healthcare.
Cheers everybody!
Always taking ticker requests
ALGN: Bullish ConsolidationAlign Tech looks poised to break higher. This bull flag on the weekly looks strong.
Risk & reward are clear. Abide by techncial stops & targets.
BAX | Catch the Falling Knife | LONGBaxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Netcare is in the Twilight Zone blowing a VuvuzelaBroadening Formation has formed on Netcare which I like to call a Vuvuzela formation.
Range bounded means the indicators are Null and Void.
We need to wait for a break above or below the broadening formation - before a trend is chosen and bias.
R15.67 to the first up target before it turns down
Baxter Inc. (BAX) bullish scenario:The technical figure Falling Wedge can be found in the daily chart in the US company Baxter International Inc. (BAX). Baxter International Inc. is an American multinational healthcare company. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The Falling Wedge broke through the resistance line on 22/03/2023. If the price holds above this level, you can have a possible bullish price movement with a forecast for the next 9 days towards 41.98 USD. According to experts, your stop-loss order should be placed at 37.35 USD if you decide to enter this position.
U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea's Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International Inc, according to people familiar with the matter.
The divestment, which the sources said could fetch more than $4 billion, would help Baxter pay down debt following its $10.5 billion acquisition of medical device maker Hill-Rom Holdings in 2021. Baxter, which has a market value of $19 billion, had total debt of $16.6 billion as of the end of December.
Private equity firms, including KKR & Co and Carlyle Group, have also expressed interest in the Baxter business, the sources said. Other bidders could still emerge, they added.
Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals and cannot be held liable nor guarantee any profits or losses.
Bayer AG (BAYN.de) bullish scenario:The technical figure Falling Wedge can be found in the daily chart in the German company Bayer AG (BAYN.de). Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals; consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The Falling Wedge broke through the resistance line on 22/03/2023. If the price holds above this level, you can have a possible bullish price movement with a forecast for the next 9 days towards 60.750 EUR. According to experts, your stop-loss order should be placed at 54.890 EUR if you decide to enter this position.
Bayer AG plans to spend $1 billion on drug research and development in the U.S. this year as it works to double its sales in the country by the end of the decade, Bayer's top U.S. pharmaceutical executive told Reuters.
Sebastian Guth, president of Bayer's pharmaceuticals business in the Americas, in an interview with Reuters, said the company increased U.S. employees working on marketing for its pharmaceutical business by around 50% over the last three years and plans to expand on that by another 75% by 2030.
Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals and cannot be held liable nor guarantee any profits or losses.
BMY | Time to Load | LONGBristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; Orencia for adult patients with active RA and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Onureg for the treatment of adult patients with AML; Inrebic, an oral kinase inhibitor indicated for the treatment of myelofibrosis; Camzyos for the treatment of adults with symptomatic obstructive HCM to enhance functional capacity and symptoms; Sotyktu for the treatment of adults with moderate-to-severe plaque psoriasis; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane, a protein-bound chemotherapy product. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
CI | A Great Pick | LONGThe Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Life Health Care group showing strong upside to R21.39 WARNINGW Formation since Sep 2022. It's been moving in a sideways range without any promising direction.
Then in February we had a breakaway gap.
This is where the price jumped from the sideways range into an uptrend.
And most sellers and stop losses were hit.
This showed strong upside to come.
7>21>200
RSI>50
Target R21.39
WARNING
Gaps like to close 70% of the time. And I don't generally like taking any trades where there are prior gaps.
I'd take this trade as a medium probability one.
could earnings disappoint tommorow?technically the bull move in this stock has left much to be desired in terms of sustainability and stability. huge moves like this have been historically quite bearish for the stock. my estimate is that the price needs major support from a catalyst like earnings or a special response from investors while even a lackluster earnings beat could disappoint bulls. if longs want to hold this price above the $2 range they need to form a continuation pattern immediately or develop sustaining momentum to keep this move up alive. im anticipating much decline in absence of this.
ABC Weekly opportunity coming soonAmerisourceBergen is a pharma company with superb growth and financials. Healthcare sector has been deeply sold off. This is a strong trending stock on the weekly (see 52 week EMA Red line). I look to add a small starter position at 154.46, the Gann Confluence Line. Will add another position should it reach either the 52 Week EMA or a RSI (12) weekly of 39 - 40. Currently RSI(12) is 46.49.
